Skip to main content
Premium Trial:

Request an Annual Quote

A New Leaf for 2011

Marking the end of one year and the beginning of another is often symbolized wiping the slate clean; retrospection, reorganization, and goal-setting are common themes at this time. To Nature, 2011 means a "new year, new science." In the next 12 months, the journal's staff expects "GWAS [to] prove their worth" as well as a "genome-sequencing explosion." Nature also predicts that in 2011, "patient-derived iPS cells will increasingly be used as models for studying medical conditions … [and] will also be used to screen potential drugs, and to probe why existing drugs help some patients but not others."

In addition, the New Scientist says that the upcoming year will mark a "crunch time for stem cells," and that two upcoming hESC trials may prove these cells' worth as reliable tools for treatments.

Over at Book of Trogol, Dorothea says that she expects 2011 to be a "challenging year" for the open access movement, though she predicts an increase in crowd-sourced data-analysis projects, and that these efforts will "pick up more good press."

Bitesize Bio's Emily Crow pledges to "update my lab notebook every day" in 2011. Among her other New Year's resolutions for the lab, she says she'll begin writing tasks "more than one week before deadline," and will also keep up on new papers "as they come out, instead of putting them in a pile to 'get to later.'" Similarly, Prodigal Academic promises to keep up on the current literature in her field and dedicate one day a week to writing only. She also aims to network outside of her specialty and "apply to at least two new ... funding agencies this year."

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.